For Press
SIR Foundation awards $1.5 million in special research grants
Four projects receive funding for high-impact interventional radiology research to further knowledge of existing IR therapies or lead to breakthrough IR therapies that improve patient outcomes
FAIRFAX, VA (Dec. 5, 2022)—The Society of Interventional Radiology (SIR) Foundation has awarded $1.5 million in grant funding to four projects exploring embolization and interventional oncology research.
The funding supports high-impact interventional radiology (IR) research that will further knowledge of existing IR therapies or lead to breakthrough IR therapies that improve patient outcomes. Two awards fund research using structured reporting and registry-based approaches, while the remaining awards fund early and conceptual-stage IR research projects that are multispecialty.
“Data supporting IR therapies are essential for expanding patient access to IR and through this special grant funding these exemplary studies will help to achieve that goal,” said SIR Foundation Chair Theresa M. Caridi, MD, FSIR, associate professor and division director of interventional radiology at the University of Alabama at Birmingham. “SIR Foundation is grateful for the support of our donors and corporate partners, which allows us to meet our mission to foster IR research and help our members care for their patients.”
The following studies were selected through a competitive review process.
Special Funding Grant—General
- Correlations of Y-90 Tumor Absorbed Dose to Histopathologic Changes and Local Tumor Control; Constantinos T. Sofocleous, MD, PhD, FSIR, from Memorial Sloan Kettering Cancer Center
- Development of a Novel Humanized Patient-derived Xenograft Model of Hepatocellular Carcinoma (HCC) for Interventional Oncology (IO); Terence Gade, MD, PhD, from the University of Pennsylvania
Special Funding Grant—Standardized/Structured Reporting
- Prospective, Multicentric Registry of Pulmonary Arteriovenous Malformation (AVM) Embolization; Clifford R. Weiss, MD, FSIR, from Johns Hopkins University
- Genetic Subtyping to Enable Precision-guided Interventions for Hepatocellular Carcinoma (HCC); Gregory J. Nadolski, MD, from the University of Pennsylvania
Visit sirfoundation.org to learn more about the 2022 Special Funding Grant—General or the 2022 Special Funding Grant—Standardized/Structured Reporting opportunities.
Elise Grant
Director, Communications and Public Relations
About the Society of Interventional Radiology
The Society of Interventional Radiology is a nonprofit, professional medical society representing more than 8,000 practicing interventional radiology physicians, trainees, students, scientists, and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR’s members work in a variety of settings and at different professional levels—from medical students and residents to university faculty and private practice physicians.
About the Journal of Vascular and Interventional Radiology
The Journal of Vascular and Interventional Radiology (JVIR), published continuously since 1990, is a monthly peer-reviewed journal serving the global community and specialty of interventional radiology. The official journal of the Society of Interventional Radiology, JVIR is the authoritative journal of choice for interventional radiologists and other collaborating physicians and scientists in imaging and minimally invasive therapeutic fields who seek current, evidence-based information on every aspect of vascular and interventional radiology. Each issue includes clinical, translational, basic science, and health policy and socioeconomic research on emerging and established domains of the specialty. Visit jvir.org.